Results 251 to 260 of about 366,020 (324)

Organ‐sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

International Journal of Cancer, EarlyView.
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval, Antoine Dardenne, Thomas Samaille, Leo Mas, Jérémie H. Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen, Thierry André   +8 more
wiley   +1 more source

The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer. [PDF]

BMC Cancer
Ahamed Y, Hossain M, Baral S, Al-Raiyan AU, Ashraf SB, Sun W.   +5 more
europepmc   +1 more source

Minimizing quantification uncertainty in nanoplasmonic platforms: Multifunctional MoS2‐integration for precise biomarker determination

InfoMat, EarlyView.
The multifunctional integration of MoS2 into the SERS platform addresses key limitations in accurate quantification. Atomically thin MoS2 reduces spot‐to‐spot variations via plasmonic calibration and improves quantification reliability by ensuring consistent signal changes with analyte concentration.
Seungkyun Lee, Seongdae Kwon, Seunghee H. Cho, Minjae Ku, Young Woo Han, Gunwoo Jo, Jeongwon Park, Hanhwi Jang, Kibum Kang, Yeon Sik Jung   +9 more
wiley   +1 more source

Organoids and organ‐on‐a‐chip models for investigating the pathophysiology of the human reproductive system

Interdisciplinary Medicine, EarlyView.
Organoids and organ‐on‐a‐chips are advancing reproductive system research. In the female reproductive system, applications include cancer organoid models, placental chips, and hormone simulation models. For the male reproductive system, research focuses on drug resistance mechanisms, co‐culture platforms, and infertility studies. These refined in vitro
Hongqi Zhang, Shiwen Deng, Fangfang Jin, Jiayao Qu, Xiang Fan, Peng Chen, Xinrong Fan   +6 more
wiley   +1 more source

Prostate specific antigen retesting intervals and trends in England: population based cohort study.

BMJ
Collins KK, Oke JL, Virdee PS, Perera R, Nicholson BD.   +4 more
europepmc   +1 more source

Diagnostic utility of serum prostate-specific antigen and circulating inflammatory markers for differentiating prostate cancer from benign prostatic hyperplasia. [PDF]

Am J Cancer Res
Luo D, Xie H.
europepmc   +1 more source

[Prostate specific antigen].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1990
E, Paus, L, Theodorsen
openaire   +1 more source

Diagnostic Efficiency of Age‐Adjusted PSAD for Prostate Cancer and Clinically Significant Prostate Cancer: Construction and Nomogram Validation

Journal of Clinical Laboratory Analysis, EarlyView.
Nomogram model performance: The study develops a predictive model using Lasso regression, incorporating key clinical factors, which achieves excellent discriminatory performance in both training and validation sets. Potential for clinical application: The A‐PSAD‐based model shows great promise for personalized PCa screening, particularly in reducing ...
Ziyang Liu, Jiahao Shan, Qiang Zhang, Yu Gao, Zhiyong Lv, Lianghong Ma, Hongbin Shi   +6 more
wiley   +1 more source

Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals.

JAMA Netw Open
Lee JR, Morehead D, Young B, Tolbert V, Masembe J, Britt G, Neuenschwander L, Schuppe K, Pelman R, Johnson D, Henderson V, Darst BF, Egwuatu P, Kim SM, Wolff EM, Gore JL, Nyame YA.   +16 more
europepmc   +1 more source

Association between Health Eating Index-2015 and prostate-specific antigen levels: a cross-sectional study of NHANES 2001-2004. [PDF]

Food Nutr Res
Di X, Zhang J, Xiang L, Wei X, Liao B.
europepmc   +1 more source